Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access April 29, 2017

Phytochemical Characterization and Biological Evaluation of the Aqueous and Supercritical Fluid Extracts from Salvia sclareoides Brot

  • Daniela Batista , Pedro L. Falé , Maria L. Serralheiro , Maria-Eduarda Araújo , Catarina Dias , Isabel Branco , Clara Grosso , José Coelho , António Palavra , Paulo J. A. Madeira , Alice Martins EMAIL logo and Amélia P. Rauter
From the journal Open Chemistry

Abstract

Plants belonging to the genus Salvia (Lamiaceae) are known to have a wide range of biological properties. In this work, extracts obtained from the aerial parts of Salvia sclareoides Brot. were evaluated to investigate their chemical composition, toxicity, bioactivity, and stability under in vitro gastrointestinal conditions. The composition of the supercritical fluid extract was determined by GC and GC-MS, while the identification of the infusion constituents was performed by HPLC-DAD and LC-MS. The in vitro cytotoxicity of both extracts (0-2 mg/mL) was evaluated in Caco-2 cell lines by the MTT assay. The anti-inflammatory and anticholinesterase activities were determined through the inhibition of cyclooxygenase-1 and acetylcholinesterase enzymes, while β-carotene/linoleic acid bleaching test and the DPPH assays were used to evaluate the antioxidant activity. The infusion inhibited cyclooxygenase-1 (IC50 = 271.0 μg/mL), and acetylcholinesterase (IC50 = 487.7 μg/ mL) enzymes, also demonstrated significant antioxidant properties, as evaluated by the DPPH (IC50 = 10.4 μg/mL) and β-carotene/linoleic acid (IC50 = 30.0 μg/mL) assays. No remarkable alterations in the composition or in the bioactivities of the infusion were observed after in vitro digestion, which supports the potential of S. sclareoides as a source of bioactive ingredients with neuroprotective, anti-inflammatory and antioxidant properties.

1 Introduction

Phytochemicals ingested daily or natural extracts used to develop new functional ingredients have become an important area of human nutritional and therapeutic research. Salvia species (Lamiaceae) have a long history of culinary and medicinal uses, so there is a remarkable interest concerning their chemistry and biological properties [1]. The industrial and economic importance of this genus has increased in recent years due to evidence that some of its secondary metabolites, mainly terpenes and polyphenols, have valuable pharmaceutical and nutraceutical properties [2]. Several clinical trials have been developed to investigate Salvia extracts, and promising results were obtained [3]. Ethnobotanical treatment strategies against Alzheimer’s disease (AD) and brain aging included the use of Salvia genus as a source of bioactive compounds [4-6]. We have focused our studies on Salvia sclareoides Brot., an Iberian endemic species, whose butanol extract revealed a promising inhibitory activity of AChE, an enzyme related to AD [7]. The phenolic profile, toxicity, antioxidant activity and prion binding properties were also studied [8]. More recently, NMR spectroscopy experiments were used to screen S. sclareoides extracts for their content in AChE ligands [9] and also for molecules that bind to Aβ 1-42 oligomers, recognized as highly toxic to AD [10].

Pursuing our studies on this plant, we report here, for the first time, the chemical composition of S. sclareoides supercritical fluid extracts as well as its cytotoxicity on Caco-2 cell line as a model of the intestinal epithelium. Because the traditional use of this plant relies on the intake of the infusion, it was also evaluated on cell assays. Since no toxicity was denoted by the infusion, it was subjected to more detailed in vitro studies involving its anti-inflammatory, anticholinesterase and antioxidant properties. In addition, the infusion was submitted to a simulated in vitro digestive process, where the antioxidant activity was monitored by the DPPH assay, and HPLC-DAD-MS/MS was used to analyze eventual alterations on chemical profile after gastric and pancreatic digestions. It is well known that inflammation and oxidative imbalance play a role in neurodegenerative impairments and so, our main goal is to explore multitarget and non-toxic plant constituents that maintain their bioactivities even after they are submitted to simulated gastrointestinal conditions. Overall, the aim of the present study is the valorization of S. sclareoides as a source of different chemical constituents that can be obtained by two complementary extraction methods. Non-polar compounds, present in volatile oils obtained by supercritical fluid extraction (SFE), and hydrophilic molecules, found in the aqueous extract, can be explored regarding their potential applications in pharmaceutical, agrochemical or food industries, giving an add-value to this natural resource.

2 Experimental Procedure

2.1 Chemicals

All chemicals were of analytical grade. MTT (thiazolyl blue tetrazolium bromide) acetylcholinesterase from electric eel, pepsin, pancreatin, COX-1 (cyclooxygenase 1) from sheep, and chemicals used to evaluate the anti-inflammatory and antioxidant activities were supplied by Sigma-Aldrich (Barcelona, Spain). DMEM (Dulbecco´s modified Eagle’s medium), HBSS (Hanks´ balanced salt solution) with and without phenol red, glutamine, Pen-Strep (penicillin and streptomycin mixture), PBS (phosphate buffered saline) and FBS (foetal bovine serum) were bought from Lonza (Verviers, Belgium). HPLC grade water, methanol and trifluoroacetic acid were obtained from Merck (Darmstadt, Germany). CO2 (99.995% purity) was supplied by Air Liquide (Lisbon, Portugal).

2.2 Plant material

Plant flowering aerial parts were collected at Serra dos Candeeiros, Portugal, and identified by Prof. Ana Isabel Correia, from the Herbarium of Jardim Botânico da Universidade de Lisboa, where a voucher specimen (LISU 233279) was deposited.

2.3 Extracts preparation

2.3.1 Supercritical fluid extract

The volatile oil from the aerial parts of S. sclareoides was obtained by SFE, using 79.05 g of plant material. SFE apparatus was described in detail in previous work [11-13], and the operational conditions of pressure, temperature, and mean particle size of plant material, CO2 flow rate, and amount of CO2 consumed were as follows: 90 bar/40 °C/0.6 mm/1.1 kg h− 1/4.6 kg, respectively.

In order to obtain a pure volatile oil free of waxes, a fractional separation was carried out at 80 bar and -8 °C (first separator), and 20 bar and -15 °C (second separator). The amount of volatile oil collected in the second separator corresponds to the combination of eight fractions collected at t = 9.95 min, t = 29.85 min, t = 58.28 min, t = 98.01 min, t = 147.18 min, t = 208.00 min, t = 237.82 min and t = 252.83 min. Extraction procedure was stopped when no more oil was obtained.

2.3.2 Aqueous extract

To prepare the infusion, boiling water (100 mL) was poured over dried plant (2.5 g) staying in infusion for 30 min. Then, it was filtered on Whatman® Grade 1 filter paper and cooled at room temperature. For HPLC-DAD analysis, the infusion (5 mL) was filtered through a 0.45 µm membrane filter (VWR) and immediately analyzed. The remaining infusion was lyophilized in a Heto Power Dry 3000 apparatus, giving the dried extract (60.24 mg), which was kept at 4 °C for further assays. Extract concentrations ranging from 0.0 to 2.0 mg/mL were prepared for bioactivity assays.

2.4 Phytochemical analysis

2.4.1 SFE extract

SFE volatile oil was analyzed by gas chromatography (GC), for component quantification, and by gas chromatography coupled to mass spectrometry (GC-MS) for component identification, as detailed in Mota et al. (2013) [14]. The identity of the components was assigned by comparison of their retention indices, relative to C9 - C16n-alkane indices and GC-MS spectra from a lab-made library (Plant Biotechnology Center, Faculty of Sciences, Lisbon University), constructed based on the analyses of reference oils, laboratory-synthesized components and commercial available standards [15].

2.4.2 Aqueous extract

HPLC-DAD and LC-MS/MS techniques were applied to the identification of infusion constituents, as previously described [16]. For HPLC-DAD analysis, S. sclareoides infusion (25 μL, 1mg/mL), was injected with an auto injector, and elution performed with a gradient composed of solution A (0.05% trifluoroacetic acid), and solution B (methanol) as following: 0 min, 80% A, 20% B; 20 min, 20% A, 80% B; 25 min, 20% A, 80% B. Regarding LC–MS and LC–MSn, the sample was analyzed by using a linear gradient composed of solution A (1.0% formic acid), and solution B (methanol) as following: 0 min, 80% A, 20% B; 20 min, 20% A, 80% B; 25 min, 20% A, 80% B. The mass spectrometer was operated in both positive and negative ion modes in the range m/z 120–1000, and the parameters were adjusted in order to optimize the signal-to-noise ratios (S/N) for the ions of interest [16].

2.5 Cytotoxicity studies with Caco-2 cells

Caco-2 cells (ATCC#HTB37), a human colorectal epithelial adenocarcinoma cell line, were cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 2 mM L-glutamine, at 37 °C, in an atmosphere with 5% CO2 [16]. The culture medium was changed every 48 to 72 h, and the cells were passaged before reaching confluence. Cytotoxicity studies were performed in 96-well plates, exposing the cells for 24 h to several concentrations (0.1 to 2.0 mg/mL) of the plant extracts in culture medium, and using the MTT viability test [17].

2.6 Anti-inflammatory activity

To study the in vitro anti-inflammatory activity, the lyophilized infusion was dissolved in Tris-buffer, pH 8, in concentrations ranging from 0.1 to 2.0 mg/mL. COX-1 activity was performed as described in previous work [18].

2.7 Acetylcholinesterase inhibition

Anti-acetylcholinesterase activity of the infusion was measured according the methodology previously reported [16], using adaptations of the method described by Ingkaninan et al. (2003) [19].

2.8 Antioxidant activity

The ability of the extract to inhibit the bleaching of the β-carotene-linoleic acid emulsion was determined using the method described by Khadri et al. (2010) [20] with a slight modification. In brief, β-carotene dissolved in chloroform (0.5 mg/mL), linoleic acid (25 μL) and Tween 40 (200 μg) were added and transferred into a round-bottom flask. When the chloroform was removed under vacuum, distilled water (50 mL) saturated with oxygen for 2 h was added to the flask with vigorous stirring. Then, 2.5 mL aliquots of this emulsion were transferred to a series of tubes containing the dissolved extract (100 μL) of each concentration and were further shaken. Absorbance of each sample was recorded at 470 nm immediately after sample preparation (t = 0 min). After that, the samples were placed in the dark for 18 h, at room temperature, together with two blanks, one containing the antioxidant BHT (butylated hydroxytoluene) as a positive control, and the other with the same volume of water instead of the extract. With the later tube a complete oxidation is obtained with the initial yellow color vanishing, while in the test tube with BHT, the yellow color is maintained during the incubation period. Tests were carried out in triplicate and the absorbance of each sample after incubation time was measured [18, 20]. Radical scavenging activity was evaluated by the DPPH method, as previously described [21].

2.9 In vitro digestions

In vitro digestions by the gastric and pancreatic juices were performed according the methodology described in [16], which was adapted from Yamamoto and co-workers (1999) [22].

2.10 Statistical analysis

All the bioassays were carried out in triplicate. The software used for data analysis was Microsoft ® Excel 2010 and the results were expressed as means ± standard deviation. Additional analysis of variance (ANOVA) was performed with P = 0.05 and P = 0.01.

3 Results and Discussion

3.1 Phytochemical analysis

3.1.1 SFE extract

The extraction yield of the volatile oil isolated by SFE from the dried flowering aerial parts of S. sclareoides was 0.4% (g/g dry weight), which is in the same range as those reported for the hydrodistilled essential oils obtained from some other species of the genus Salvia [23-25], but lower than that of S. officinalis [26]. Regarding SFE, the yields reported in the literature for Salvia species are more variable and depend on the pressure and temperature conditions used for the extractions, and are higher for higher pressures [27-28]. At pressures above 90/100 bar, other compounds may contaminate the volatile oil inducing the increase of the extraction yield [12]. Therefore, a pressure/temperature set of 90 bar/40 °C was selected in this work to guarantee that the chemical composition of the volatile oil was free of heavier compounds, namely the waxes present in plants.

The chemical composition of the volatile oil obtained by SFE from S. sclareoides was analyzed by GC-MS. As can be seen in Table 1, it was dominated by trans-β- caryophyllene oxide, hexadecanoic acid, phytol acetate 2, linoleic acid ethyl ester and hexadecanoic acid methyl ester. On the other hand, monoterpene hydrocarbons were present in trace amounts and oxygen containing monoterpenes were absent.

Table 1

Composition of the volatiles extracted by supercritical fluid extraction (SFE) from the dried flowering aerial parts of Salvia sclareoides.

ComponentsRISFE§
12345678
Benzaldehyde927tttttttt
α-Pinene930tttttttt
1-Octen-3-ol961tttttttt
β-Pinene963tttttttt
Benzene acetaldehyde1002tttttttt
Limonene1009tttttttt
n-Nonanal10730.50.3tttttt
cis-Theaspirane1286tttttttt
trans-Theaspirane1300tttttttt
n-Tridecane1300tttttttt
Bicycloelemene1544tttttttt
δ-Elemene1332tttttttt
β-Elemene1388tttttttt
trans-β-Caryophyllene14142.71.5tttttt
Guaia-6,9-diene[*]14475.22.9tttttt
α-Humulene14470.50.3tttttt
trans-β-Farnesene14550.5ttttttt
β-Ionone14560.4ttttttt
Bicyclogermacrene14873.12.80.6ttttt
α-trans-trans-Farnesene1500tttttttt
Elemol15304.50.3tttttt
trans-Nerolidol15490.4ttttttt
Spathulenol1551t1.0tttttt
trans-β-Caryophyllene oxide15619.45.51.53.10.7ttt
Globulol15662.23.00.80.6tttt
α-Bisabolol1656tttttttt
α-trans-Bergamotol1669tttttttt
Hexadecanoic acid (= palmitic190814.612.617.121.332.135.520.927.6
acid)
Phytol acetate 2204715.427.040.828.918.114.519.215.1
Linoleic acid ethyl ester213715.011.014.019.519.014.319.618.3
Hexadecanoic acid methyl ester213715.114.420.520.527.530.939.137.0
% of Identification89.582.695.393.997.495.298.898.0
Grouped Components
Monoterpene hydrocarbonstttttttt
Sesquiterpene hydrocarbons12.07.50.6ttttt
Oxygen-containing16.59.82.33.70.7ttt
sesquiterpenes
C13 components0.4ttttttt
Others60.665.392.490.296.795.298.898.0

RI = Retention index relative to C9-C22n-alkanes on the DB-1 column; t = trace (<0.05%). § Eight fractions of volatile oil collected in the second separator at different times.

The chemical variability among different species of Salvia is well known. These results contrast with those described for other Salvia species submitted to SFE, such as S. lavandulifolia Vahl. [29], and S. officinalis L. [30-31], which were richer in monoterpene hydrocarbons and the main compounds were oxygen containing monoterpenes [1,8-cineole, (E)-ocimenone and camphor]. Moreover, hydrodistilled essential oils of several species of Salvia are mainly composed by monoterpene hydrocarbons (α- and β-pinene, limonene) or oxygen containing monoterpenes (1,8-cineole, camphor, α-thujone, α-terpinenyl acetate, linalool), depending on the species, and less commonly, sesquiterpenes are the major compounds (β-caryophyllene, caryophyllene oxide) [23-26]. On the other hand, the hydrodistilled essential oils of some less studied Salvia species contains fatty acids and their esters as well as diterpenoids in considerable amounts, such as, S. hierosolymitana (21% of fatty acids and 4.8% of phytol) [32], S. sclarea (12.77% of phytol) [33], S. splendens Scarlet Sage Red (10.99% of fatty acids and 41.46% of phytol) [34], and S. dorisiana (3.99% of fatty acids and 10.81% of phytol) [34]. S. ceratophylla (29.0% of fatty acids and 14% of phytol) [35], S. miltiorrhiza (28.8% of fatty acids and aliphatic esters and 8.9% of phytol) [36], S. glutinosa (13.7% of phytol) [37], and S. reflexa (28% of fatty acids and 3% of phytol isomer) [37]. In addition, SFE of S. desoleana obtained at 90 bar and 50 °C was rich in the diterpenoid sclareol (74.6%), a compound also found in the hydrodistilled oil (5%) [38].

Apart from the current study on the apolar fraction of S. sclareoides, only one study assessing the composition of its essential oil obtained by hydrodistillation has been published. As shown by Sepahvand et al. (2014) [39], the essential oil of S. sclareoides obtained by hydrodistillation was a complex mixture mainly composed by linalool (27.6%), trans-caryophyllene (16.6%), β-trans-ocimene (11.8%), germacrene-D (10%), bicyclogermacrene (3.3%), caryophyllene oxide (2.9%), linalyl acetate (2.7%), 1-octanol (2.0%), spathulenol (1.6%) and cis-ocimene (1.4%). Lower amounts of β-pinene, β-elemene, α-humulene, phytol and α-farnesene were also found, among other minor compounds. Comparing this composition with that obtained through using SFE, eight compounds were in common, and in both cases the presence of high amounts of sesquiterpenes was verified, conversely to the amount of monoterpenes.

The evolution of the volatile oil composition with the extraction time was also evaluated in this study and, as it can be seen in Table 1, changes were observed. Sesquiterpene hydrocarbons were only extracted in the first hour of extraction, while oxygen-containing sesquiterpenes were present in the fractions collected until 147.18 min (2.45 h). On the other hand, fatty acids and their derivatives as well as the diterpenoid phytol acetate 2 were extracted since the beginning of the extraction but corresponded to 98% of the volatile oil at the end of the extraction. Similar behavior was observed by other authors [29, 30] who described that monoterpene hydrocarbons and oxygen containing monoterpenes were mainly extracted at the beginning, with the percentage of lighter components decreasing with the extraction time. Conversely, higher-molecular-weight compounds, such as sesquiterpene hydrocarbons and oxygenated sesquiterpenes showed a continuous percentage increase at increasing extraction times. The authors explained this behavior by considering that lighter compounds have shorter internal diffusion times than heavier ones and are, thus, more readily available. To the best of our knowledge this is the first report on the chemical composition of the SFE-volatile oil, free of waxes, from S. sclareoides, contributing to the extent of knowledge on the chemical composition of the genus Salvia.

3.1.2 Aqueous extract

The infusion of S. sclareoides was analyzed by HPLC-DAD (Fig.1) and its main components were tentatively identified by LC-MS/MS (Table 2).

Figure 1 HPLC-DAD chromatogram of Salvia sclareoides infusion: (1) unknown, (2) luteolin diglucuronide, (3) sagerinic acid, (4) rosmarinic acid, (5) luteolin-7-O-(6´´- O-acetylglucoside).
Figure 1

HPLC-DAD chromatogram of Salvia sclareoides infusion: (1) unknown, (2) luteolin diglucuronide, (3) sagerinic acid, (4) rosmarinic acid, (5) luteolin-7-O-(6´´- O-acetylglucoside).

Table 2

Putative identification of compounds present in Salvia sclareoides infusion by LC-MS.

PeakRT[M-H]-Main productCompound
(min)ions(m/z)
13.5223178,118,113,Unknown
89
28.6637381, 351, 285Luteolin diglucuronide
39.1719539, 521, 359,Sagerinic acid
341
411.1359197, 179, 161Rosmarinic acid
(Massbank score 0.732,
Massbank IDPR100686)
512.5489285, 241, 199,Luteolin acetylglucoside
175, 151(Massbank score for
the aglycone 0.941,
Massbank ID BML00144)

The identification of each peak (Fig. 1 and Table 2) was based on the fragmentation patterns in MS2 and MS3 experiments, and comparison with literature and Mass Bank data base [40].

Rosmarinic acid was identified as the major component of the infusion, and its fragmentation pattern is in full agreement with the previously reported data [9, 41]. In addition, this compound has also been appointed as the major constituent of other Salvia species [1, 42]. Luteolin derivatives, like luteolin diglucuronide [1], and luteolin-7-O-(6´´O-acetylglucoside) [9], as well as sagerinic acid [43], were also detected in minor amounts in the S. sclareoides infusion.

3.2 Toxicity evaluation in Caco-2 cells

Extracts´ cytotoxicity was evaluated by the MTT (methylthiazolyldiphenyl-tetrazolium bromide) method. It is based on the cellular reduction of tetrazolium salts to dyed formazan-based products by mitochondrial dehydrogenases, providing information on cell metabolism [44]. Despite some limitations of this method, when applied to plant extracts [45-46], it is a rapid and inexpensive assay for a preliminary cell viability evaluation. Although infusions of S. sclareoides are taken traditionally by people, the cytotoxicity of its SFE extracts remains unknown. The extracts were analyzed concerning their toxicity towards Caco-2 cell line, which is an accepted model for intestinal cells [47]. The cells were incubated 24 h with different concentrations (0.1-2 mg/mL) of the extracts and, even with the highest concentration (2 mg/mL), the inhibitions were below 50% for all extracts (Fig. 2) and therefore IC50 values could not be reached.

Figure 2 Toxicity of the infusion (Inf.) and of the first three fractions (SFE1-3) of the supercritical fluid extract from Salvia sclareoides for Caco-2 cells, presented as % of decrease in cell viability.* Values statistically different from the control (P < 0.05).
Figure 2

Toxicity of the infusion (Inf.) and of the first three fractions (SFE1-3) of the supercritical fluid extract from Salvia sclareoides for Caco-2 cells, presented as % of decrease in cell viability.

* Values statistically different from the control (P < 0.05).

None of the extracts tested can be considered toxic as generally IC50 values above 0.1 mg/mL are referred as non-toxic [48]. However, with 2 mg/mL, the three first fractions of the SFE extract presented toxicities significantly different from 0% (the control, untreated cells), respectively, SFE1 (13.5 ± 2.4%), SFE2 (12.4 ± 1.1%) and SFE3 (19.7 ± 3.2%), in opposition to the infusion that showed no significant toxicity (0.39 ± 0.55%) even with 2 mg/mL (Fig. 2). Therefore, caution must be taken when ingesting the SFE extracts, as the toxic values may be more easily reached and cause gastrointestinal problems, when compared to the infusion. These results also show that the traditional preparation of S. sclareoides extracts as an infusion may be the safest way of ingesting the plant extract, and so, we pursued our research work on bioactivities of the lyophilized infusion.

3.3 Anti-inflammatory activity

Non-steroid anti-inflammatory drugs have important therapeutic interest in the treatment of inflammatory diseases, since they are widely used for the treatment of pain, inflammation and fever. It is assumed that the main mechanism of action of these drugs consists in the inhibition of the cyclooxygenase enzymes: the constitutive cyclooxygenase-1 (COX-1) and the inducible cyclooxygenase-2 (COX-2) isoenzymes that catalyze the conversion of arachidonic acid into prostaglandins (PGs), whose contribution to the process of inflammation is well known [49]. Recently, COX-1 isoenzyme has been receiving increased attention, also because of its involvement in many health problems [50]. In brain, COX-1, predominantly localized in microglia, is an important player in neuroinflammation [51], being involved in several neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury, among others [50]. In order to investigate the potential of COX-1 as therapeutic target, selective COX-1 inhibitors have been developed [52]. These findings encouraged us to evaluate the ability of S. sclareoides infusion to inhibit COX-1 and we found that it inhibited the enzyme (IC50 = 271.0 ± 4.0 μg/mL) in a dose dependent manner, evidencing a moderate inhibitory activity.

3.4 Acetylcholinesterase inhibition

The infusion of this plant is traditionally used for the prevention of cognitive detrimental status. Once acetylcholinesterase is an enzyme involved in the depletion of the neurotransmitter acetylcholine, its inhibition may be a target to reverse cognitive disorders. S. sclareoides infusion significantly inhibited the enzyme AChE (IC50 = 487.7 ± 14.8 μg/mL). Rosmarinic acid, the major phenolic component of the infusion, has shown to be an inhibitor of the acetylcholinesterase activity [53], and so we can assume that this phenolic compound has an important role on the anticholinesterase effect of the herbal tea. To corroborate this assumption, our previous studies on NMR spectroscopy binding experiments of S. sclareoides crude extracts in the presence of AChE, determined rosmarinic acid as the only explicit binder to this enzyme [9].

3.5 Antioxidant capacity

Antioxidant activity was evaluated through two different assays: β-Carotene/linoleic acid bleaching test and DPPH free radical-scavenging activity. In the first, a model system made of β-carotene and linoleic acid undergoes a rapid discoloration in the absence of an antioxidant. The free linoleic acid radical formed upon the abstraction of a hydrogen atom from one of its methylene groups attacked the β-carotene molecules, which lost the double bonds and therefore its characteristic orange color [54]. Regarding the DPPH test, it measures the capacity of the extracts to scavenge the stable radical 2,2-diphenyl-1-picrylhydrazyl formed in solution. If the extracts have the capacity to scavenge the DPPH free radical, the initial blue/purple solution will change to a yellow color, due to the formation of diphenylpicrylhydrazine [55].

When evaluated by the β-carotene assay, S. sclareoides infusion presented an IC50 of 30.0 ± 5.9 μg/mL, indicating that the extract has a significant antioxidant activity, when compared to the synthetic antioxidant BHT (IC50 = 4.5 ± 0.8 mg/mL). Regarding the DPPH assay, the obtained IC50 (10.4 ± 0.4 mg/mL) evidences a good radical scavenging activity. When compared to other extracts from the same plant species, also studied by our group [8], the infusion evidences a better antioxidant activity in both assays. Regarding other Salvia species, although their chemical variability and the different method of extract preparation influence bioactivities, our results add further support to the well documented antioxidant and anticholinesterase properties of extracts from this genus [56-60], evidencing their potential for therapeutic exploitation.

3.6 In vitro digestion by gastric and pancreatic juices and remaining bioactivities

In traditional medicine, S. sclareoides is taken orally, meaning that infusion components are subjected to gastrointestinal conditions. An in vitro simulation of such conditions allows to predict absorption and distribution of its components assuring that they can exert their bioactivities. The in vitro digestions were made with artificial gastric and pancreatic juices, mimicking the digestion in the gastrointestinal tract, and the infusion was analyzed, in the beginning and after digestion, by HPLC. Moreover, the antioxidant and anti-acetylcholinesterase activities were also evaluated.

The composition of the plant extract was not significantly altered neither in gastric nor in pancreatic digestion, which is in accordance with previous studies showing the stability of rosmarinic acid, the main component, under in vitro digestive conditions [61-63]. Concerning the extract bioactivities, no significant alterations were observed in the antioxidant activity after the digestion with gastric juice (99.3 ± 9.4%), which agrees with the HPLC analysis that showed no remarkable changes in the extract composition. After pancreatic digestion, the final antioxidant activity (100.5 ± 8.3%) remained similar to the initial one, indicating that the main antioxidant components of the infusion persisted intact. It is known that AChE inhibitors stimulate gastrointestinal motility [61], enhancing the potential purgative properties of S. sclareoides infusion. Although a slight decrease in the acetylcholinesterase inhibition was observed after pancreatic digestion (82.4 ± 8.1%), the inhibitory capacity of the extract increased to 105.3 ± 10.9% after gastric digestion. This demonstrates that the plant infusion is not only active, but also that its bioactive components may reach the intestine.

Dietary intervention studies in several mammalian species, using phenolic rich extracts, have indicated an ability to improve memory, by protecting vulnerable neurons, or by stimulating neuronal regeneration [64]. In addition, the anti-inflammatory properties of phenolic compounds [65], contribute to their neuroprotective effects through their capacity to reduce oxidative imbalance. Based on these findings, S. sclareoides can be regarded as an important source of multitarget bioactive molecules with potential to the prevention of neurodegenerative and age-related chronic diseases.

4 Conclusions

SFE can be regarded as an adequate methodology to obtain volatiles from S. sclareoides in good yields. Although, at high concentrations, the SFE extract has denoted some cytotoxicity to Caco-2 cells, when compared to the infusion, its potential to be used for agricultural and pharmaceutical formulations with antimicrobial properties needs to be explored. Regarding the non-toxic aqueous extract, a simulated in vitro digestion, evidenced no remarkable alterations in the composition or in the bioactivities, suggesting that the infusion can pass through the gastrointestinal tract, keeping its composition and biological properties. The present work reinforces the results of our previous research on S. sclareoides extracts and adds further support to the use of the infusion as a source of multitarget bioactive molecules with potential application on the prevention and treatment of neurodegenerative diseases.

Acknowledgements

This work was supported by Fundação para a Ciência e a Tecnologia (FCT), Project UID/MULTI/00612/2013 and UID/QUI/50006/2013. FCT is also acknowledged for PJAM post-doctoral fellowship (SFRH/BPD/86948/2012) and for CG FCT Investigator (IF/01332/2014). The European Commission is also acknowledged for approval of the INOVAFUNAGEING commitment and the support of the projects PERSSILAA-FP7-ICT-2013-10, Project Nr. 610359, and D3i4AD, FP7-PEOPLE-2013-IAPP, GA 612347. The authors also gratefully acknowledge the collaboration of Prof. Ana Cristina Figueiredo (DBV-FCUL), for GC and GC-MS analysis, and of Prof. Maria Helena Florêncio (DQB-FCUL) for LC-MS support.

  1. Conflict of interest: The authors declare there is no conflicts of interest.

References

[1] Cvetkovikj I., Stefkov G., Acevska J., Stanoeva J.P., Karapandzova M., Stefova M., et al., Polyphenolic characterization and chromatographic methods for fast assessment of culinary Salvia species from South East Europe, J. Chromatogr. A, 2013, 128, 238-245.10.1016/j.chroma.2012.12.068Search in Google Scholar PubMed

[2] Marchev A., Haas C., Schulz S., Georgiev V., Steingroewer J., Bley T., et al., Sage in vitro cultures: a promising tool for the production of bioactive terpenes and phenolic substances, Biotechnol. Lett., 2014, 36, 211-221.10.1007/s10529-013-1350-zSearch in Google Scholar PubMed

[3] Bonito M.C., Cicala C., Marcotullio M.C., Maione F., Mascolo N., Biological activity of bicyclic and tricyclic diterpenoids from Salvia species of immediate pharmacological and pharmaceutical interest, Nat. Prod. Commun., 2011, 6, 1205-1215.10.1177/1934578X1100600839Search in Google Scholar

[4] Howes M.J.R., Perry E., The role of phytochemicals in the treatment and prevention of dementia, Drug Aging, 2011, 28, 439-468.10.2165/11591310-000000000-00000Search in Google Scholar PubMed

[5] Howes M.J.R., Houghton P.J., Ethnobotanical treatment strategies against Alzheimer’s disease, Curr. Alzheimer Res., 2012, 9, 67-85.10.2174/156720512799015046Search in Google Scholar PubMed

[6] Russo P., Frustaci A., Del Bufalo A., Fini M., Cesario A., From traditional European medicine to discovery of new drug candidates for the treatment of dementia and Alzheimer’s disease: acetylcholinesterase inhibitors, Curr. Med. Chem., 2013, 20, 976-983.10.2174/092986713805288905Search in Google Scholar

[7] Rauter A.P., Branco I., Lopes R.G., Justino J., Silva F.V.M., Noronha J.P., et al., A new lupenetriterpenetriol and anticholinesterase activity of Salvia sclareoides, Fitoterapia, 2007, 78, 474-481.10.1016/j.fitote.2007.02.013Search in Google Scholar PubMed

[8] Rauter A.P., Dias C., Martins A., Branco I., Neng N.R., Nogueira J.M., et al., Non-toxic Salvia sclareoides Brot. extracts as a source of functional food ingredients: phenolic profile, antioxidant activity and prion binding properties, Food Chem., 2012, 132, 1930-1935.10.1016/j.foodchem.2011.12.028Search in Google Scholar

[9] Marcelo F., Dias C., Martins A., Madeira P.J., Jorge T., Florêncio M.H., et al., Molecular recognition of rosmarinic acid from Salvia sclareoides extracts by acetylcholinesterase: a new binding site detected by NMR spectroscopy, Chem. Eur. J., 2013, 19, 6641-6649.10.1002/chem.201203966Search in Google Scholar PubMed

[10] Airoldi C., Sironi E., Dias C., Marcelo F., Martins A., Rauter A.P., et al., Natural compounds against Alzheimer’s disease: molecular recognition of A beta 1-42 peptide by Salvia sclareoides extract and its major component, rosmarinic acid, as investigated by NMR, Chem. Asian J., 2013, 47, 596-602.10.1002/asia.201201063Search in Google Scholar PubMed

[11] Reis-Vasco E.M., Coelho J.A., Palavra A.M.F., Comparison of penny royal oils obtained by supercritical CO2 extraction and hydrodistillation, Flavour Frag. J., 1999, 14, 156-160.10.1002/(SICI)1099-1026(199905/06)14:3<156::AID-FFJ793>3.0.CO;2-JSearch in Google Scholar

[12] Grosso C., Figueiredo A.C., Burillo J., Mainar A.M., Urieta J.S., Barroso J.G., Enrichment of the thymoquinone content in volatile oil from Satureja montana using supercritical fluid extraction, J. Sep. Sci., 2009, 32, 328-334.10.1002/jssc.200800490Search in Google Scholar

[13] Grosso C., Coelho J.A., Urieta J.S., Palavra A.M.F., Barroso J.G., Herbicidal activity of volatiles from coriander, winter savory, cotton lavender and thyme isolated by hydrodistillation and supercritical fluid extraction, J. Agric. Food Chem., 2010, 58, 11007-11013.10.1021/jf102378dSearch in Google Scholar

[14] Mota L., Figueiredo A.C., Pedro L.G., Barroso J.G., Ascensão L., Glandular trichomes, histochemical localization of secretion and essential oil composition in Plectranthus grandidentatus growing in Portugal, Flavour Frag. J., 2013, 28, 393-401.10.1002/ffj.3175Search in Google Scholar

[15] Faria J.M.S, Barbosa P., Bennett R.N., Mota M., Figueiredo A.C., Bioactivity against Bursaphelenchus xylophilus: Nematotoxics from essential oils, essential oils fractions and decoction waters, Phytochemistry, 2013, 94, 220-228.10.1016/j.phytochem.2013.06.005Search in Google Scholar

[16] Falé P.L., Ferreira C., Rodrigues A.M., Cleto P., Madeira P.J.A., Florêncio M.H., et al., Antioxidant and anti-acetylcholinesterase activity of commercially available medicinal infusions after in vitro gastrointestinal digestion, J. Med. Plants Res., 2013, 7, 1370-1378.10.5897/JMPR13.4438Search in Google Scholar

[17] Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to the proliferation and cytotoxicity assays, J. Immunol. Methods, 1983, 65, 55-63.10.1016/0022-1759(83)90303-4Search in Google Scholar

[18] Amessis-Ouchemoukh N., Madani K., Falé P.L.V., Serralheiro M.L., Araújo M.E.M., Antioxidant capacity and phenolic contents of some Mediterranean medicinal plants and their potential role in the inhibition of cyclooxygenase-1 and acetylcholinesterase activities, Ind. Crop Prod., 2014,53, 6-15.10.1016/j.indcrop.2013.12.008Search in Google Scholar

[19] Ingkaninan K., Temkitthawon P., Chuenchon K., Yuyaem T., Thongnoi W., Screening for acetylcholinesterase inhibitory activity in plants used in Thai traditional rejuvenating and neurotonic remedies, J. Ethnopharmacol., 2003, 89, 261-264.10.1016/j.jep.2003.08.008Search in Google Scholar

[20] Khadri A., Neffati M., Smiti S., Falé P., Lino A.R.L., Serralheiro M.L.M. et al., Antioxidant, anti-acetylcholinesterase and antimicrobial activities of Cymbopogon schoenanthus L. Spreng (lemon grass) from Tunisia, LWT-Food Sci. Technol., 2010, 43, 331-336.10.1016/j.lwt.2009.08.004Search in Google Scholar

[21] Falé P.L., Borges C., Madeira P.J.A., Ascensão L., Araújo M.E.M, Florêncio M.H. et al., Rosmarinic acid, scutellarein 4’-methyl ether 7-O-glucuronide and (16S)-coleon E are the main compounds responsible for the anti-acetylcholinesterase and antioxidant activity in herbal tea of Plectranthus barbatus, Food Chem., 2009, 114, 798-805.10.1016/j.foodchem.2008.10.015Search in Google Scholar

[22] Yamamoto Y., Takahashi Y., Kawano M., lizuka M., Matsumoto T., Saeki S., et al., In vitro digestibility and fermentability of levan and its hypocholesterolemic effects in rats. J. Nutr. Biochem., 1999, 10, 13-18.10.1016/S0955-2863(98)00077-1Search in Google Scholar PubMed

[23] Tepe B., Donmez E., Unlu M., Candan F., Daferera D., Vardar-Unlu G., et al., Antimicrobial and antioxidative activities of the essential oils and methanol extracts of Salvia cryptantha (Montbretet Aucher ex Benth.) and Salvia multicaulis (Vahl), Food Chem., 2004, 84, 519-525.10.1016/S0308-8146(03)00267-XSearch in Google Scholar

[24] Tepe B., Daferera D., Sokmen A., Sokmen M., Polissiou M., Antimicrobial and antioxidant activities of the essential oil and various extracts of Salvia tomentosa Miller (Lamiaceae), Food Chem., 2005, 90, 333-340.10.1016/j.foodchem.2003.09.013Search in Google Scholar

[25] Sonboli A., Babakhani B., Mehrabian A.R., Antimicrobial activity of six constituents of essential oil from Salvia, Z. Naturforsch. C, 2006, 61, 160-164.10.1515/znc-2006-3-401Search in Google Scholar PubMed

[26] Perry N.B., Anderson R.E., Brennan N.J., Douglas M.H., Heaney A.J., McGimpsey J.A. et al., Essential oils from dalmatian sage (Salvia officinalis L.): Variations among individuals, plant parts, seasons, and sites, J. Agric. Food Chem., 1999, 47, 2048-2054.10.1021/jf981170mSearch in Google Scholar PubMed

[27] Yamini Y., Khajeh M., Ghasemi E., Mirza M., Javidnia K., Comparison of essential oil compositions of Salvia mirzayanii obtained by supercritical carbon dioxide extraction and hydro distillation methods, Food Chem., 2008, 108, 341-346.10.1016/j.foodchem.2007.10.036Search in Google Scholar

[28] Glisic S., Ivanovic J., Ristic M., Skala D., Extraction of sage (Salvia officinalis L.) by supercritical CO2: Kinetic data, chemical composition and selectivity of diterpenes, J. Supercrit. Fluids, 2010, 52, 62-70.10.1016/j.supflu.2009.11.009Search in Google Scholar

[29] Langa E., Della Porta G., Palavra A.M.F., Urieta J.S., Mainar A.M., Supercritical fluid extraction of spanish sage essential oil: Optimization of the process parameters and modelling, J. Supercrit. Fluids, 2009, 49, 174-181.10.1016/j.supflu.2008.12.007Search in Google Scholar

[30] Reverchon E., Taddeo R., Della Porta G., Extraction of sage oil by supercritical CO2: Influence of some process parameters, J. Supercrit. Fluids, 1995, 8, 302-309.10.1016/0896-8446(95)90005-5Search in Google Scholar

[31] Gañán N., Brignole E. A. Supercritical carbon dioxide fractionation of T. minuta and S. officinalis essential oils: Experiments and process analysis, J. Supercrit. Fluids, 2013, 78, 12-20.10.1016/j.supflu.2013.03.019Search in Google Scholar

[32] Mancini E., Arnold N. A., De Martino L., De Feo V., Formisano C., Rigano D., Senatore, F., Chemical composition and phytotoxic effects of essential oils of Salvia hierosolymitana Boiss. and Salvia multicaulis Vahl. var. simplicifolia Boiss. growing wild in Lebanon, Molecules, 2009, 14, 4725-4736.10.3390/molecules14114725Search in Google Scholar PubMed PubMed Central

[33] Taarit M. B., Msaada K., Hosni K., Marzouk B., Physiological changes and essential oil composition of clary sage (Salvia sclarea L.) rosette leaves as affected by salinity, Acta Physiol. Plant., 2011, 33, 153-162.10.1007/s11738-010-0532-8Search in Google Scholar

[34] Mathew J., Thoppil, J. E., Chemical composition and mosquito larvicidal activities of Salvia essential oil, Pharm. Biol., 2011, 49, 456-463.10.3109/13880209.2010.523427Search in Google Scholar PubMed

[35] Mohammadi M., Yousefi M., Habibi Z., Rahmati S., Imanzadeh G., Volatile Constituents of Salvia ceratophylla L. and Salvia indica L. from Iran, J. Essent. Oil Bear. Pl., 2010, 13, 774-780.10.1080/0972060X.2010.10643894Search in Google Scholar

[36] Li X., Wang Z., Chemical composition, antimicrobial and antioxidant activities of the essential oil in leaves of Salvia miltiorrhiza Bunge, J. Essent. Oil Res., 2009, 21, 476-480.10.1080/10412905.2009.9700222Search in Google Scholar

[37] Malenčić D., Couladis M., Mimica-Dukić N., Popović M., Boža P., Essential oils of three Salvia species from the Pannonian part of Serbia, ↱Flavour Frag. J., 2004, 19, 225-228.10.1002/ffj.1291Search in Google Scholar

[38] Posadino A. M., Porcu M. C., Marongiu B., Cossu A., Piras A., Porcedda S., Falconieri D., Cappuccinelli R., Bios G., Pintus G., Pretti L., Antioxidant activity of supercritical carbon dioxide extracts of Salvia desoleana on two human endothelial cell models, Food. Res. Int., 2012, 46, 354-359.10.1016/j.foodres.2011.12.019Search in Google Scholar

[39] Sepahvand R., Delfan B., Ghanbarzadeh S., Rashidipour M., Veiskarami G.H., Ghasemian-Yadegari J., Chemical composition, antioxidant activity and antibacterial effect of essential oil of the aerial parts of Salvia sclareoides, Asian Pac. J. Trop. Med., 2014, 7, S491-S496.10.1016/S1995-7645(14)60280-7Search in Google Scholar PubMed

[40] Horai H., Arita M., Kanaya S., Nihei Y., Ikeda T., Suwa. K., et al., MassBank: A public repository for sharing mass spectral data for life sciences, J. Mass Spectrom., 2010, 45, 703-714.10.1002/jms.1777Search in Google Scholar PubMed

[41] M⊘ller J.K.S., Catharino R.R., Eberlin M.N., Electrospray ionization mass spectrometry fingerprinting of essential oils: Spices from the Labiatae family, Food Chem., 2007, 100, 1283-1288.10.1016/j.foodchem.2005.10.013Search in Google Scholar

[42] Zimmermann B.F., Stephan G., Walch S.G., Tinzoh L.N., Stühlinger W., Lachenmeier D.W., Rapid UHPLC determination of polyphenols in aqueous infusions of Salvia officinalis L. (sage tea), J. Chromatogr. B, 2011, 79, 2459-2464.10.1016/j.jchromb.2011.06.038Search in Google Scholar PubMed

[43] Barros L., Dueñas M., Dias M.I., Sousa M.J., Santos-Buelga C., Ferreira I.C., Phenolic profiles of cultivated, in vitro cultured and commercial samples of Melissa officinalis L. infusions, Food Chem., 2013, 136, 1-8.10.1016/j.foodchem.2012.07.107Search in Google Scholar PubMed

[44] Ciappellano S.G., Tedesco E., Venturini, M., Benetti F., In vitro toxicity assessment of oral nanocarriers, Adv. Drug Deliv. Rev., 2016, 106, 381-401.10.1016/j.addr.2016.08.007Search in Google Scholar PubMed

[45] Wisman K.N., Perkins A.A., Jeffers M.D., Hagerman A.E., Accurate assessment of the bioactivities of redox-active polyphenolics in cell culture, J. Agric. Food Chem., 2008, 56 (17), 7831-7837.10.1021/jf8011954Search in Google Scholar PubMed

[46] Bruggisser R., von Daeniken K., Jundt G., Schaffner W., Tullberg-Reinert H., Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay, Planta Med., 2002, 68(5), 445-448.10.1055/s-2002-32073Search in Google Scholar PubMed

[47] Hilgers A.R., Conradi R.A., Burton P.S., Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa, Pharm. Res., 1990, 7, 902-910.10.1023/A:1015937605100Search in Google Scholar

[48] Okonogi S., Duangrat C., Anuchpreeda S., Tachakittirungrod S., Chowwanapoonpohn S., Comparison of antioxidant capacities and cytotoxicity of certain fruit peels, Food Chem., 2007, 103, 839-846.10.1016/j.foodchem.2006.09.034Search in Google Scholar

[49] Ulbrich H., Fiebich B., Dannhardt G., Cyclooxygenase -1/2 (Cox-1/Cox-2) and (5-LOX) inhibitors of the 6, 7-diaryl-2, 3-1 H-dihydropyrrolizine type, Eur. J. Med. Chem., 2002, 37, 953-959.10.1016/S0223-5234(02)01418-6Search in Google Scholar

[50] Perrone M.G., Scilimati A., Simone L., Vitale P., Selective COX-1 inhibition: A therapeutic target to be reconsidered, Curr. Med. Chem., 2010, 17 (32), 3769-3805.10.2174/092986710793205408Search in Google Scholar PubMed

[51] Bosetti F., Choi S-H., Rethinking the role of cyclooxygenase-1 in neuroinflammation, Cell Cycle, 2010, 9(15), 2919-2920.10.4161/cc.9.15.12715Search in Google Scholar PubMed

[52] Perrone M.G., Vitale P., Malerba P., Altomare A., Rizzi R., Lavecchia A., Di Giovanni C., Novellino E., Scilimati A., Diarylheterocycle core ring features effect in selective COX-1 inhibition, ChemMedChem., 2012, 7, 629-641.10.1002/cmdc.201100530Search in Google Scholar PubMed

[53] Falé P.L., Ascensão L., Serralheiro M.L., Haris P.I., Interaction between Plectranthus barbatus herbal tea components and acetylcholinesterase: Binding and activity studies, Food Funct., 2012, 3, 1176-1184.10.1039/c2fo30032jSearch in Google Scholar PubMed

[54] Lai H.Y., Lim Y.Y., Evaluation of antioxidant activities of the methanolic extracts of selected ferns in Malaysia, Int. J. Environ. Sci. Develop., 2011, 2 (6), 442-447.10.7763/IJESD.2011.V2.166Search in Google Scholar

[55] Khadhri A., Bouali I., Belkhir S., Mokded R., Smiti S., Falé P., Araújo, M.E.M., Serralheiro M.L.M., In vitro digestion, antioxidant and antiacetylcholinesterase activities of two species of Ruta: Ruta chalepensis and Ruta montana, Pharm. Biol., 2016, 55 (1), 101-107.10.1080/13880209.2016.1230634Search in Google Scholar PubMed PubMed Central

[56] Sallam A., Mira A., Ashour, A., Shimizu, K., Acetylcholine esterase inhibitors and melanin synthesis inhibitors from Salvia officinalis, Phytomedicine, 2016, 23, 1005-1011.10.1016/j.phymed.2016.06.014Search in Google Scholar PubMed

[57] Senol F.S., Orhan I.E., Erdem S.A., Kartal M., Sener B., Kan Y., Celep F., Kahraman A., Dogan M., Evaluation of cholinesterase inhibitory and antioxidant activities of wild and cultivated samples of sage (Salvia fruticosa) by activity-guided fractionation, J. Med. Food., 2011, 14 (11), 1476-1483.10.1089/jmf.2010.0158Search in Google Scholar PubMed

[58] Suntar I., Akkol E.K., Senol F.S., Keles H., Orhan I.E., Investigating wound healing, tyrosinase inhibitory and antioxidant activities of the ethanol extracts of Salvia cryptantha and Salvia cyanescens using in vivo and in vitro experimental models, J. Ethnopharmacol., 2011, 135, 71–77.10.1016/j.jep.2011.02.022Search in Google Scholar PubMed

[59] Orhan I., Aslan M., Appraisal of scopolamine-induced antiamnesic effect in mice and in vitro antiacetylcholinesterase and antioxidant activities of some traditionally used Lamiaceae plants, J. Ethnopharmacol., 2009, 122, 327-332.10.1016/j.jep.2008.12.026Search in Google Scholar PubMed

[60] Orhan I.E., Kartal M., Naz Q., Ejaz A., Yilmaz G.I., Kan Y., Konuklugil B., Sener B.M., Choudhary I., Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species, Food Chem., 2007, 103 (4), 1247-1257.10.1016/j.foodchem.2006.10.030Search in Google Scholar

[61] Porfírio S., Falé P.L., Madeira P.J.A., Florêncio M.H., Ascensão L., Serralheiro M.L.M., Anti-acetylcholinesterase and antioxidant activities of Plectranthus barbatus tea, after in vitro gastrointestinal metabolism, Food Chem., 2010, 122, 179-187.10.1016/j.foodchem.2010.02.044Search in Google Scholar

[62] Gião M.S., Gomes S., Madureira A.R., Faria A., Pestana D., Calhau C., et al., Effect of in vitro digestion upon the antioxidant capacity of aqueous extracts of Agrimonia eupatoria, Rubus idaeus, Salvia sp. and Satureja montana, Food Chem., 2012, 131, 761-767.10.1016/j.foodchem.2011.09.030Search in Google Scholar

[63] Costa P., Grevenstuk T., Costa A.R., Gonçalves S., Romano A., Antioxidant and anti-cholinesterase activities of Lavandula viridis L’Hér extracts after in vitro gastrointestinal digestion, Ind. Crop Prod., 2014, 55, 83-89.10.1016/j.indcrop.2014.01.049Search in Google Scholar

[64] Kumar G.P., Khanum F., Neuroprotective potential of phytochemicals, Pharm. Rev., 2012, 6(12), 81-90.10.4103/0973-7847.99898Search in Google Scholar PubMed PubMed Central

[65] Ambriz-Pérez D.L., Leyva-López N., Gutierrez-Grijalva E.P., Heredia J.B., Phenolic compounds: Natural alternative in inflammation treatment. A Review, Cogent Food Agric., 2016, 2, 1131412.10.1080/23311932.2015.1131412Search in Google Scholar

Received: 2015-8-17
Accepted: 2017-3-29
Published Online: 2017-4-29

© 2017 Daniela Batista et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 19.3.2024 from https://www.degruyter.com/document/doi/10.1515/chem-2017-0011/html
Scroll to top button